The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis: A network pharmacology and molecular docking study

BACKGROUND: At present, there was no evidence that any drugs other than lung transplantation can effectively treat Idiopathic Pulmonary Fibrosis (IPF). Ligusticum wallichii, or Chinese name Chuan xiong has been widely used in different fibrosis fields. Our aim is to use network pharmacology and mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaozheng, Li, Wen, Luo, Zhenliang, Chen, Yunzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830865/
https://www.ncbi.nlm.nih.gov/pubmed/35147109
http://dx.doi.org/10.1097/MD.0000000000028787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830865/
https://www.ncbi.nlm.nih.gov/pubmed/35147109
http://dx.doi.org/10.1097/MD.0000000000028787

Ejemplares similares